PubMed · 16869304
[Transferrin conjugates in the anticancer therapy].
Abstract
To enhance the therapeutic efficiacy of anticancer drugs and reducing its systemic side-effects carriers are used. Transferrin is one of the very promising protein which can be used to transport drugs, DNA and ions into the cancer cells. Because of the fact that neoplastic cells have increased number of transferrin receptors, the transferrin can deliver the drugs directly to the neoplastic cells without injury of normal cells.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Dorota Lubgan, Agnieszka Marczak, Luitpold Distel, Zofia Jóźwiak. 2006. [Transferrin conjugates in the anticancer therapy].. https://pubmed.ncbi.nlm.nih.gov/16869304/
Cite the original work for its findings. Save a collection to share your selection of sources.